Table 1.
Clinical and Demographic Data of the Studied Population
| Characteristics | SCC (N=32) | MCI (N=41) | Sig. |
|---|---|---|---|
| Age, y | 68 (61–72) | 72 (67–73) | 0.030 |
| Sex | |||
| Females | 11 (34.37%) | 15 (36.58%) | 0.854 |
| Males | 21 (65.62%) | 26 (63.41%) | |
| Education, y | 10 (8–15) | 8 (4–10) | 0.058 |
| APOE-ε4 | 6 (23.07%) | 9 (25.71%) | 0.813 |
| Fazekas 1 | 19 (67.85%) | 20 (55.55%) | 0.664 |
| Fazekas 2 | 6 (21.42%) | 11 (30.55%) | |
| Fazekas 3 | 3 (10.71%) | 5 (13.88%) | |
| Hypertension | 25 (78.12%) | 31 (75.06%) | 0.801 |
| Dyslipidemia | 23 (71.87%) | 35 (85.36%) | 0.157 |
| DM | 8 (25%) | 13 (31.07%) | 0.530 |
Note: Data is presented as N (%) or Median (IQR).
Abbreviations: SCC, Subjective Cognitive Complaints; MCI, Mild Cognitive Impairment; Sig., statistical significance; Y, years; DM, Diabetes Mellitus.